Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
LycellVax
- Development stage
- Unknown
- Lead developer
- Oncobiomed
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Intradermal
01
Overview
LycellVax is a polyvalent cancer vaccine developed by Oncobiomed, a Chilean biotechnology company. It consists of an immunogenic tumor cell lysate derived from multiple tumor cell lines, designed to expose the patient's immune system to a broad array of tumor-associated antigens. The vaccine aims to induce a robust, polyvalent antitumor immune response, overcoming the limitations of single-antigen vaccines. LycellVax is a core component of Oncobiomed's TAPCells technology, where it is used to pulse autologous dendritic cells to enhance their ability to prime T-cells against cancer. Clinical development has reached Phase 1/2 for indications including melanoma, prostate cancer, and colon cancer.
- Brand names
- LycellVax
- Other names
- LycellVax
02
Targets
HT-ATCL (Multiple tumor-associated antigens derived from heat-treated allogeneic tumor cell lysates)
Beyond the preview
Go deeper on LycellVax.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on LycellVax.